The AACR and the Biden Administration
On January 20, 2021, Joseph R. Biden was inaugurated as the 46th president of the United States. The AACR has worked with Mr. Biden since 2016, when during his term as Vice President he was appointed by then-President Barack Obama to lead the National Cancer Moonshot Initiative. Vice President Biden addressed attendees at the AACR Annual Meeting that year, and he returned to the Annual Meeting again in 2017. The AACR will continue to work with the Biden-Harris administration during their term to advance progress for cancer patients. A summary of the AACR’s interactions with the administration is provided below.
The AACR applauds President Biden’s address, which highlighted notable initiatives that would spur innovation and advance cancer research and patient care.
In a White House briefing attended by AACR CEO Margaret Foti, PhD, MD (hc), President Biden announced a goal of reducing the death rate from cancer by 50 percent during the next 25 years.
Five of the seven presidential appointees to the National Cancer Advisory Board were AACR members, including John D. Carpten, PhD, FAACR who will serve as chair.
A letter from the White House affirmed his support for lifesaving cancer research.
More than 130 organizations joined the AACR in signing a letter to President Biden requesting that cancer patients and survivors recieve priority access to COVID-19 vaccines.
From the AACR Blog
January 29, 2021
The AACR has worked with President Biden since 2016 to advance cancer research.Learn More
January 20, 2021
On Inauguration Day, the AACR journal Cancer Discovery asked prominent scientists how the Biden administration might approach cancer research funding and patient care.